
12/09/2025
The (FDA) approved Xeomin® in July 2011 for the treatment of severe frown lines or “11’s” between the eyes. Xeomin's "pure" formulation without complexing proteins may be an advantage for patients developing resistance to Botox.
Our Botoxology Appointment Coordinator, Brianna Bedell, is waiting to book your appointment - please call 940-736-0011 or email her at info@botoxology.com.